Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1952 1
1953 1
1955 1
1956 1
1957 6
1958 4
1959 2
1960 2
1961 1
1962 2
1963 2
1965 3
1966 1
1967 1
1968 1
1969 1
1971 2
1972 1
1973 3
1974 2
1975 2
1976 2
1977 1
1978 3
1979 2
1980 1
1981 3
1982 2
1983 6
1984 6
1985 11
1986 10
1987 15
1988 9
1989 12
1990 15
1991 12
1992 30
1993 28
1994 28
1995 24
1996 44
1997 41
1998 52
1999 44
2000 52
2001 75
2002 61
2003 94
2004 98
2005 105
2006 126
2007 130
2008 157
2009 232
2010 280
2011 279
2012 307
2013 319
2014 374
2015 394
2016 440
2017 521
2018 555
2019 614
2020 336
Text availability
Article attribute
Article type
Publication date

Search Results

5,427 results
Results by year
Filters applied: . Clear all
Page 1
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP. Chen N, et al. Among authors: Yu KP. N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24. N Engl J Med. 2019. PMID: 31340116 Clinical Trial.
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP. Chen N, et al. Among authors: Yu KP. N Engl J Med. 2019 Sep 12;381(11):1001-1010. doi: 10.1056/NEJMoa1813599. Epub 2019 Jul 24. N Engl J Med. 2019. PMID: 31340089 Clinical Trial.
Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity.
Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, Fu L, Yang J, Pan Z, Yu K, He J, Morand E, Schlecht-Louf G, Krzysiek R, Zitvogel L, Kang B, Zhang Z, Leader A, Zhou P, Lanfumey L, Shi M, Kroemer G, Ma Y. Yang H, et al. Among authors: Yu K. Nat Med. 2019 Sep;25(9):1428-1441. doi: 10.1038/s41591-019-0566-4. Epub 2019 Sep 9. Nat Med. 2019. PMID: 31501614
The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function.
Oberbeck N, Pham VC, Webster JD, Reja R, Huang CS, Zhang Y, Roose-Girma M, Warming S, Li Q, Birnberg A, Wong W, Sandoval W, Kőműves LG, Yu K, Dugger DL, Maltzman A, Newton K, Dixit VM. Oberbeck N, et al. Among authors: Yu K. Nature. 2019 Oct;574(7777):249-253. doi: 10.1038/s41586-019-1615-3. Epub 2019 Oct 2. Nature. 2019. PMID: 31578523
NaCl Nanoparticles as a Cancer Therapeutic.
Jiang W, Yin L, Chen H, Paschall AV, Zhang L, Fu W, Zhang W, Todd T, Yu KS, Zhou S, Zhen Z, Butler M, Yao L, Zhang F, Shen Y, Li Z, Yin A, Yin H, Wang X, Avci FY, Yu X, Xie J. Jiang W, et al. Among authors: Yu KS, Yu X. Adv Mater. 2019 Nov;31(46):e1904058. doi: 10.1002/adma.201904058. Epub 2019 Sep 25. Adv Mater. 2019. PMID: 31553099
Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer.
Ponz-Sarvise M, Corbo V, Tiriac H, Engle DD, Frese KK, Oni TE, Hwang CI, Öhlund D, Chio IIC, Baker LA, Filippini D, Wright K, Bapiro TE, Huang P, Smith P, Yu KH, Jodrell DI, Park Y, Tuveson DA. Ponz-Sarvise M, et al. Among authors: Yu KH. Clin Cancer Res. 2019 Nov 15;25(22):6742-6755. doi: 10.1158/1078-0432.CCR-19-1398. Epub 2019 Sep 6. Clin Cancer Res. 2019. PMID: 31492749 Free PMC article.
5,427 results
Jump to page
Feedback